UK markets closed

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
26.22+0.05 (+0.19%)
At close: 04:00PM EDT
26.38 +0.16 (+0.61%)
After hours: 07:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
52,604
36,275
52,121
33,053
57,994
Operating expenses
Research development
449,800
435,069
419,979
229,807
150,408
Selling general and administrative
120,140
116,497
90,306
71,096
44,169
Total operating expenses
569,940
551,566
510,285
300,903
194,577
Operating income or loss
-517,336
-515,291
-458,164
-267,850
-136,583
Total other income/expenses net
-18,650
-15,733
-24,564
-1,325
-
Income before tax
-485,502
-481,192
-474,186
-267,892
-134,231
Income from continuing operations
-485,502
-481,192
-474,186
-267,892
-134,231
Net income
-485,502
-481,192
-474,186
-267,892
-134,231
Net income available to common shareholders
-485,502
-481,192
-474,186
-267,892
-134,231
Basic EPS
-5.34
-5.42
-6.16
-3.78
-2.40
Diluted EPS
-5.34
-5.42
-6.16
-3.78
-2.40
Basic average shares
86,468
88,770
76,972
70,894
55,987
Diluted average shares
89,098
88,770
76,972
70,894
55,987